Global Mouse Monoclonal Antibody Production Service Market Growth (Status and Outlook) 2025-2031

The global Mouse Monoclonal Antibody Production Service market size is predicted to grow from US$ 625 million in 2025 to US$ 842 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031.

Mouse monoclonal antibody production service is a specialized offering provided by biotech companies or research institutions. It involves a series of complex biological processes where a specific antigen is introduced into a mouse, triggering its immune system to produce antibodies. Splenocytes from the immunized mouse are then fused with myeloma cells to create hybridoma cells. These hybridomas are screened and cloned to isolate those that produce the desired monoclonal antibody, which is highly specific to the target antigen. The service provider then scales up the production of this monoclonal antibody, purifies it to a high degree, and delivers it to clients, who can be researchers for use in experiments, or pharmaceutical companies for drug development and diagnostic applications.

Key Features

• Market Growth
• Service Providers
• Target Customers

Segmentation by Type

• Hybridoma Technology
• Phage Display Technology
• Single B Cell Cloning Technology

Segmentation by Application

• Biomedical Research
• Diagnostics
• Others

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage

• Thermo Fisher Scientific
• GenScript
• Sino Biological
• ProMab
• Sydlabs
• Rockland Immunochemicals, Inc
• Boster Bio
• Antibodies Incorporated
• Creative Diagnostics
• Synaptic Systems
• Inotiv Bioproducts
• ProSpec
• Applied Biological Materials Inc. (abm)
• Creative Biolabs
• Abvigen
• R&D Systems
• Eurogentec

Key Questions Addressed in this Report

• What is the market size and growth forecast for the Mouse Monoclonal Antibody Production Service industry?
• What are the key trends and growth drivers in the market?
• Who are the key players and what is their market share?